Low-density lipoprotein receptor–related protein 1 mediatesα-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's diseaseOA
α-Synuclein accumulation and transmission are vital to the pathogenesis of Parkinson''s disease,although the mechanisms underlying misfoldedα-synuclein accumulation and propagation have not been conclusively determined.The expression of low-density lipoprotein receptor–related protein 1,which is abundantly expressed in neurons and considered to be a multifunctional endocytic receptor,is elevated in the neurons of patients with Parkinson''s disease.However,whether there is a direct link between low-density lipoprotein receptor–related protein 1 andα-synuclein aggregation and propagation in Parkinson''s disease remains unclear.Here,we established animal models of Parkinson''s disease by inoculating monkeys and mice withα-synuclein pre-formed fibrils and observed elevated low-density lipoprotein receptor–related protein 1 levels in the striatum and substantia nigra,accompanied by dopaminergic neuron loss and increasedα-synuclein levels.However,low-density lipoprotein receptor–related protein 1 knockdown efficiently rescued dopaminergic neurodegeneration and inhibited the increase inα-synuclein levels in the nigrostriatal system.In HEK293A cells overexpressingα-synuclein fragments,low-density lipoprotein receptor–related protein 1 levels were upregulated only when the N-terminus ofα-synuclein was present,whereas anα-synuclein fragment lacking the N-terminus did not lead to low-density lipoprotein receptor–related protein 1 upregulation.Furthermore,the N-terminus ofα-synuclein was found to be rich in lysine residues,and blocking lysine residues in PC12 cells treated withα-synuclein pre-formed fibrils effectively reduced the elevated low-density lipoprotein receptor–related protein 1 andα-synuclein levels.These findings indicate that low-density lipoprotein receptor–related protein 1 regulates pathological transmission ofα-synuclein from the striatum to the substantia nigra in the nigrostriatal system via lysine residues in theα-synuclein N-terminus.
Hanjiang Luo;Caixia Peng;Chengli Wu;Chengwei Liu;Qinghua Li;Shun Yu;Jia Liu;Min Chen
Laboratory of Neuroscience,Guangxi Neurological Diseases Clinical Research Center,Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Key Laboratory of Brain and Cognitive Neuroscience,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Engineering Research Center of Digital Medicine and Clinical Translation,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,ChinaLaboratory of Neuroscience,Guangxi Neurological Diseases Clinical Research Center,Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Key Laboratory of Brain and Cognitive Neuroscience,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,ChinaLaboratory of Neuroscience,Guangxi Neurological Diseases Clinical Research Center,Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Key Laboratory of Brain and Cognitive Neuroscience,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,ChinaLaboratory of Neuroscience,Guangxi Neurological Diseases Clinical Research Center,Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Key Laboratory of Brain and Cognitive Neuroscience,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,ChinaLaboratory of Neuroscience,Guangxi Neurological Diseases Clinical Research Center,Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Key Laboratory of Brain and Cognitive Neuroscience,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Engineering Research Center of Digital Medicine and Clinical Translation,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,ChinaDepartment of Neurobiology,Xuanwu Hospital,Capital Medical University,Beijing,ChinaBeijing Institute of Brain Disorders,Laboratory of Brain Disorders,Ministry of Science and Technology,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing,ChinaLaboratory of Neuroscience,Guangxi Neurological Diseases Clinical Research Center,Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Key Laboratory of Brain and Cognitive Neuroscience,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China Guangxi Engineering Research Center of Digital Medicine and Clinical Translation,Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China
医药卫生
α-synucleindopaminergic neurodegenerationinternalizationlow-density lipoprotein receptor-related protein 1lysinepre-formed fibrilmovement disordernigrostriatal systemParkinson''s diseasetransmission
《Neural Regeneration Research》 2026 (4)
P.1595-1606,12
supported by the Natural Science Foundation of Guangxi Zhuang Automomous Region,Nos.2019GXNSFDA245015(to MC),2022GXNSFBA035654(to HL)the National Natural Science Foundation of China,Nos.82360241(to MC),82304876(to HL)Scientific Research and Technology Development Project of Guilin City,Nos.20220139-3(to MC),20210218-5(to HL)Guangxi Medical and Health Key Discipline Construction Project(to QL)。
评论